S&P 500 7,627.14 −0.47%
Nasdaq 26,001.87 −0.03%
S&P/TSX 35,570.99 −1.12%
Apple 348.26 +0.01%
Nvidia 212.85 +0.30%
Microsoft 523.53 +0.47%
Shopify 234.00 −1.02%
Royal Bank 278.70 −1.44%
CAD/USD 0.7154 +0.46%
LIVE · 10:15 ET
Market ClerkRecap
Fri Oct 23 · markets open6 signals today103 insider buys this week · $208.8MCIRO short report next: Oct 31The week ahead

ADMA

ADMA BIOLOGICS, INC.
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
10.62
−0.33 −3.01%
USD · close Oct 23

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $2.4BP/E 15.2DIV YIELD —FCF YIELD 4.90%REV TTM $512.3M +8.0%NET INCOME $169M −19.1%NET DEBT $60.6M52W 7.60 – 20.38SEC XBRL · TTM TO Invalid Date

What ADMA had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
No 8-K filings from ADMA on record yet. The events worker reads new filings each morning; older ones appear as the sweep reaches them.

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch ADMA. Know when insiders buy.
One email the day a filing lands. Free.